Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000318306-08-000060
Filing Date
2008-10-23
Accepted
2008-10-22 17:42:28
Documents
3
Period of Report
2008-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDMENT NO. 2 a10ka2_123107.htm 10-K/A 81625
2 CEO CERTIFICATION ex_31-1a.htm EX-31.1 15836
3 CFO CERTIFICATION ex_31-2a.htm EX-31.2 15839
  Complete submission text file 0000318306-08-000060.txt   114927
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15771 | Film No.: 081135880
SIC: 2834 Pharmaceutical Preparations